COP regimen
|
WikiDoc Resources for COP regimen |
|
Articles |
|---|
|
Most recent articles on COP regimen Most cited articles on COP regimen |
|
Media |
|
Powerpoint slides on COP regimen |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on COP regimen at Clinical Trials.gov Clinical Trials on COP regimen at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on COP regimen
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on COP regimen Discussion groups on COP regimen Patient Handouts on COP regimen Directions to Hospitals Treating COP regimen Risk calculators and risk factors for COP regimen
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for COP regimen |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: CVP; CVP regimen; Cyclophosphamide/Vincristine/Prednisone
Overview
COP regimen refers to a regimen consisting of cyclophosphamide, vincristine, and prednisone used to treat Non Hodgkin's lymphoma.
Regimen
CCyclophosphamide
OVincristine (Oncovin)
PPrednisone
Indications
References
- ↑ Luce JK, Gamble JF, Wilson HE, Monto RW, Isaacs BL, Palmer RL; et al. (1971). "Combined cyclophosphamide vincristine, and prednisone therapy of malignant lymphoma". Cancer. 28 (2): 306–17. PMID 4935774.